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The unnatural isotope fluorine-18 ( 18 F) is used as a positron emitter in molecular imaging. Currently, many potentially useful 18 F-labeled probe molecules are inaccessible for imaging, because no fluorination chemistry is available to make them. Syntheses must be rapid on account of the 110-minute half-life of 18 F and benefit from using Positron emission tomography (PET) is a noninvasive imaging technology used to observe and probe biological processes in vivo (1, 2) . While several positron-emitting isotopes can be used for PET imaging, fluorine-18 ( 18 F) is the most clinically relevant radioisotope (3, 4) . For example, the radiotracer [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) has revolutionized clinical diagnosis in oncology. Despite the success of PET and decades of research, there remains a major deficiency in the ability to synthesize complex PET tracers; in fact, no general method is available to radiolabel structurally complex molecules with 18 F. In organic molecules, fluorine atoms are typically attached by carbon-fluorine bonds (5) , yet carbon-fluorine bond formation is challenging, especially in the presence of the variety of functional groups commonly found in structurally complex molecules (6) . For PET applications, chemical challenges are exacerbated by the short half-life of 18 F (110 minutes), which dictates that carbon-fluorine bond formation occur at a late-stage in the synthesis to avoid unproductive radioactive decay before injection in vivo.
The unnatural isotope 18 Research toward PET tracer development has focused on the use of [ 18 F]fluoride to make PET tracers in high specific activity. Incorporation of 18 F still most commonly relies on simple nucleophilic substitution reactions, a class of reactions originally developed more than 100 years ago (7) and often not suitable to address modern challenges in imaging.
Recent advances in nucleophilic fluorination (8-11) include a palladium-catalyzed fluorination reaction of aryl triflates with anhydrous cesium fluoride developed by the Buchwald group, in which carbonfluorine bond formation proceeds by reductive elimination from palladium(II) aryl fluoride complexes (12, 13) . Challenges associated with the application of fluorination reactions to PET include the requirement of short reaction times as well as different reaction conditions for 18 F-chemistry compared to 19 Fchemistry. For example, extensive drying of fluoride is readily achieved for 19 Fchemistry, but can be impractical for radiochemistry, which is typically executed on a nanomole scale. The smaller ratio of fluorine to water, when transitioning from 19 F-chemistry to 18 F-chemistry, can be problematic, because hydrated fluoride has diminished nucleophilicity. As a consequence, even promising modern fluorination reactions developed for 19 F-chemistry are often not translated to radiochemistry.
Electrophilic fluorination reactions allow access to a complementary set of molecules when compared to nucleophilic fluorination reactions (6) . Yet, all electrophilic 18 (15) . However, nucleophilic [ 18 F]fluoride is currently the only practical and generally available source of fluorine to prepare high specific activity PET tracers (3) . If an electrophilic fluorination reagent were to be made from fluoride (16, 17) , without the need for F 2 , electrophilic fluorination could become a general and widely used method to prepare PET tracers that are presently inaccessible via conventional nucleophilic fluorination chemistry.
Previously, we reported the fluorination of palladium aryl complexes with the electrophilic fluorination reagent F-TEDA ( Fig. 1) (18) . F-TEDA can oxidize palladium(II) aryl complexes, which subsequently afford aryl fluorides by carbonfluorine reductive elimination from palladium(IV) aryl fluoride complexes (19, 20) .
Replacement of F-TEDA by a fluorination reagent that mimics the function of F-TEDA, but is made from fluoride has the potential for use in the synthesis of high specific activity 18 F-radiotracers. Here we report the design and synthesis of an organometallic complex made from fluoride (1 → 2, Fig. 1 ) that behaves as an electrophilic fluorination reagent, and the use of the reagent for the synthesis of 18 Late transition metals such as palladium, when in a high oxidation state, can function as an oxidant and transfer a ligand to a nucleophile, while being reduced in the process to a lower oxidation state (21) . The palladium in 2 can function as an electron acceptor, which rationalizes the reactivity of 2 as an oxidant. iii) The supporting benzo[h]quinolyl and tetrapyrazole borate (Tp) ligands are multidentate ligands that were selected to impart stability on both 1 and 2 toward undesired reductive processes such as carbon-fluorine reductive elimination. Reductive elimination from 2 would likely require dissociation of one ligand to form a pentacoordinate palladium complex (19, 20) , and multidentate ligands such as Tp are less likely to dissociate and hence reduce the rate of potential reductive elimination. iv) An octahedral Pd(IV) complex was chosen to avoid undesired nucleophilic attack at the transition metal. The palladium-fluorine bond is polarized toward fluorine, with partial negative charge on fluorine and positive charge on palladium. Solely based on coulombic interactions, nucleophilic attack is expected at palladium rather than fluorine. However, the orbitals available for nucleophilic attack on octahedral (t 2g ) 6 (e g ) 0 Pd(IV) complexes, the d x 2 -y 2 and d z 2 orbitals, are high in energy, and nucleophilic attack on high energy orbitals is disfavored (22) . v) The multidentate supporting ligands in 2 feature aromatic substituents to prevent nucleophilic attack on the carbon and nitrogen atoms coordinated to palladium. Complex 2 was devised to act as an electrophilic fluorination reagent through nucleophilic attack at the antibonding palladium-fluorine-based orbital (σ* Pd-F ) at fluorine in an S N 2 reaction. In such a putative S N 2 reaction, palladium would function as a leaving group, with concomitant reduction to the oxidation state +II (Pd(II)). Nucleophilic attack would occur at the lowest unoccupied molecular orbital (LUMO) of 2. The calculated LUMO of 2 (Fig.   2B ), shows that only the lobe on fluorine points into unoccupied space; no other LUMO lobe is available for nucleophilic attack because the aromatic ligands block the trajectories.
Treatment of the palladium complex 1 with nucleophilic fluoride (KF) afforded the palladium fluoride complex 2 within five minutes in 90% yield ( Fig. 2A) . The ability of 67-93% yield (Fig. 3 ). We propose that Pd(IV) fluoride complex 2 oxidizes the Pd(II) aryl complexes by fluorine transfer to form high-valent Pd(IV) aryl fluoride complexes, analogous to 5, from which carbon-fluorine reductive elimination can occur to form aryl fluoride products 12-15. The aryl fluoride molecules shown in Figure 3 were selected based on their structure and exhibition of a variety of functional groups, akin to potential small-molecule PET tracers (25, 26) . The molecules are electron-rich arenes, which would be challenging to prepare by conventional fluorination reactions with [ 18 F]fluoride.
The transition from 19 F-chemistry to 18 F-chemistry is challenging because the concentration of the limiting reagent, fluoride, changes from mM to µM, and syntheses must be performed in the presence of ionizing radiation and under a time constraint due to the 110-minute half-life of 18 F. Therefore, reaction chemistry applicable to 18 Fchemistry must be robust and as simple as possible for broad applications in medical imaging. Organometallic synthesis in a hospital setting would be impractical. However, the palladium complexes discussed here can be prepared conveniently on scale, stored, and subsequently transported to imaging sites when needed. The palladium(II) aryl complexes such as 8-11 can be purified by chromatography or recrystallization and can be stored and transported in air at ambient temperature. Palladium complex 1 is stable at room temperature and can be manipulated briefly in air. Palladium complex 2 is stable toward heat (no observed decomposition for 24 hours at 100 ºC), and water (no observed decomposition in 10% aqueous acetonitrile solution after 3 hours at 23 ºC). Thermal stability and tolerance toward water are beneficial for practical PET applications, because reaction mixtures are often heated to increase reaction rates and [ 18 F]fluoride is made from oxygen-18-enriched water.
The synthesis of 18 F-radiolabeled molecules using the presented fluoride-derived reagent is operationally simple. Pd(IV) complex 1 reacts with conventionally prepared solutions of [ 18 F]fluoride in acetone and forms the 18 F-reagent [ 18 F]2 within ten minutes (Fig 4) .
Subsequent filtration over a polymer-supported resin and addition of the Pd(II) aryl complexes 9-11 afforded, upon heating for ten minutes, the 18 The efficiency of radiochemical synthesis is given in radiochemical yield, which is based on decay-corrected radioactivity rather than on mass of isolated material (4) .
Radiochemical yields (RCYs) as high as possible are desired, but RCYs as low as 5% can provide meaningful PET imaging (27) . The 18 F-fluorination method described here has afforded RCYs higher than 30%.
Stoichiometric amounts of precious transition metals such as palladium are typically avoided in syntheses of health care products due to toxicity and cost considerations.
However, such considerations are different for the synthesis of PET tracers due to the small amount that is required (28) . High-specific activity PET tracers are administered at a dose at least two orders of magnitude smaller than is common for pharmaceuticals because pharmacological effects are not sought (29) , and purification is often straightforward due to the small amount of tracer to be purified. For example, inductively coupled plasma mass spectrometry (ICP-MS) analysis of [ 18 F]13 (Fig. 4) , purified by conventional HPLC technique (20 minutes), afforded material with 5 parts per billion (ppb) palladium residue, commensurate with international recommendations on the palladium impurity profile for samples injected into humans, which demand less than 1000 ppb palladium (30) . Similarly, the synthesis cost for the palladium complexes is small compared to the cost of 18 F-isotope infrastructure and the cost associated with clinical imaging (31) .
We have shown that the presented late-stage fluorination reaction can access 18 
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